ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,450,304 | +24.9% | 35,757 | +1.7% | 0.03% | +20.8% |
| Q3 2022 | $1,161,000 | +6.2% | 35,143 | +13.2% | 0.02% | +14.3% |
| Q2 2022 | $1,093,000 | -24.1% | 31,047 | -0.9% | 0.02% | -4.5% |
| Q1 2022 | $1,441,000 | -40.6% | 31,326 | -14.3% | 0.02% | -37.1% |
| Q4 2021 | $2,424,000 | -22.4% | 36,557 | -3.0% | 0.04% | -28.6% |
| Q3 2021 | $3,123,000 | 0.0% | 37,705 | 0.0% | 0.05% | +19.5% |
| Q2 2021 | $3,123,000 | +33.1% | 37,705 | +6.5% | 0.04% | +17.1% |
| Q1 2021 | $2,347,000 | -56.9% | 35,392 | -50.1% | 0.04% | -58.3% |
| Q4 2020 | $5,442,000 | +246.8% | 70,920 | +94.6% | 0.08% | +211.1% |
| Q3 2020 | $1,569,000 | – | 36,438 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |